Navigation Links
Victoria Forges Global Alliance with Dow AgroSciences for Crop Innovation
Date:5/19/2009

ATLANTA, May 19 /PRNewswire/ -- Victoria has forged a global alliance with Dow AgroSciences for crop innovation, Minister for Innovation of Victoria Gavin Jennings announced today at BIO2009 in Atlanta.

The research partnership will see Victoria strengthen its position as a leader in agricultural biotechnology as scientists in Australia and the USA work together to develop new plant traits and plant varieties for Victorian and international farmers.

The agreement - that established a significant collaborative R&D effort between the Victorian Department of Primary Industries (DPI) and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company -- is the largest international agricultural biotechnology alliance undertaken by the Victorian Government to date.

"This joint research and development effort will accelerate the creation of unique solutions," said Mr. Jennings.

"We are committed to driving world-leading innovation in science, technology and practice, to enable farmers to respond to pressures such as climate change and to maintain a sustainable agriculture industry for the benefit of all Victorians," said Mr. Jennings.

Mr. Jennings joined Jerome Peribere, Dow AgroSciences president and CEO, and Daniel R. Kittle, Ph.D., Dow AgroSciences vice president for Research & Development, at BIO2009 to sign the agreement.

"Victoria is clearly establishing itself as a global leader in agricultural biotechnology and Dow AgroSciences is pleased to set up this unique collaboration with DPI's capabilities based at the Victorian AgriBiosciences Centre, in which technologies and scientific expertise will be shared to deliver plant-based solutions that contribute to improving the quality of life for the world's growing population," said Kittle.

"The initial research projects will focus on the development of agronomically important technologies that will improve yields in crops to meet growing global demands for food, feed and energy," said Professor German Spangenberg, DPI's executive director of Biosciences Research who is to lead the R&D efforts in Victoria.

"One of the key crops will include canola, which is the third largest crop in Australia, and will further enhance Dow AgroSciences' Omega-9 canola oil platform. Other crops targeted in this large-scale research partnership between DPI and Dow AgroSciences will include traits for corn and wheat as well as bioenergy crops," Kittle said.

About Victoria's Biosciences Research Centre

The new $230 million Biosciences Research Centre, a joint venture between the Victorian Government and La Trobe University, will boost Victoria's ability to make these important scientific discoveries. To be located in Bundoora, Melbourne, the facility will be a world-class centre for agricultural biosciences research and development. Other agencies and organisations with complementary science objectives are invited to partner or link in to the new Centre. Learn more at www.dpi.vic.gov.au/brc.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), are $4.5 billion. Learn more at www.dowagro.com.


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Micell Forges Strategic Agreement to Develop Advanced Drug-Eluting Stents and Balloons
2. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
3. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
4. Paragon Bioservices, Inc. Wins 2009 Lilly Global Supplier Award
5. A Global View: NanoLogix Creates Science Advisory Board
6. Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young
7. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
8. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
9. Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing
10. Matt Bars, a Global Expert in Smoking Cessation, Joins Next Safety as Chairman
11. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):